Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/26/2023
CDE Issues the Guide to Compilation of Drug Package Inserts (Abbreviat...
11/24/2023
China Concludes Tendering Process of 9th VBP amid Reform to Improve ...
11/24/2023
CDE Solicits Comments on the Technical Guidelines for Application of D...
11/24/2023
Drug R&D and Product Registration News Digest 11/2023 (2)
11/24/2023
Recent Executive Moves
11/24/2023
China Gearing Up to Take on Pharmaceutical Giants, Drive Biotech Boom ...
11/24/2023
China Biopharma: Charting a Path to Value Creation (McKinsey)
11/23/2023
PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
11/23/2023
Myricx Concludes Global Licence Deal for WuXi Bio's Antibody
11/23/2023
CDE Solicits Comments on the Guidelines for BE Studies of Dydrogestero...
11/23/2023
CDE Solicits Comments on the Technical Guidelines for Safety Informati...
11/23/2023
State Council Approves the Draft Implementation Rules of the Patent L...
11/22/2023
Acrometa to Strengthen Biopharma Presence in China by Developing Co-Wo...
11/22/2023
Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
11/21/2023
MNCs Unveil Initiatives at CIIE to Deepen Connection with Chinese Pati...
11/21/2023
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differe...
11/21/2023
AstraZeneca and Usynova Strike Global License Deal for KRASG12D Inhib...
11/21/2023
Connect Bio and Simcere Pharma Announce Exclusive License Deal for Rad...
11/21/2023
Bimeda Opens £22M China Plant
11/21/2023
Tencent Sets Sights on China's Multibillion-Dollar Healthcare Sector w...
11/20/2023
China Moves to Enhance Cancer Survival Rates with New Action Plan
11/20/2023
China Issues New Work Plan to Curb Heart and Brain Diseases
11/20/2023
Roche to Further Explore China's Personalized Healthcare Market Poten...
11/20/2023
Chiesi Signs License Deal with Haisco for a Novel, Reversible DPP1 In...
11/20/2023
Aurobindo Pharma's China Plant Gets EU's GMP Approval
11/20/2023
Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
11/17/2023
CDE Publicizes the List of Reference Formulations for GQCE Studies (76...
11/17/2023
China Begins Formal Access Negotiation for the 2023 NRDL
11/17/2023
JPO Announces the Final 9th VBP Tender Outcome
11/17/2023
Recent Official and Executive Moves
Page:
26
/
718
Total number of articles:
21536
:
[First]
[<<]
[24]
[25]
[26]
[27]
[28]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit